Market Overview

Markets are grinding higher with the S&P 500 and Nasdaq at record highs, driven by three converging forces: US-Iran peace deal progress crashing oil prices (-4.7% on WTI to $92.94), a raging semiconductor/AI rally (SOXL +291% YTD), and SpaceX’s IPO filing electrifying the space sector. The tech-led advance is broadening into travel, airlines, and cruise lines as lower fuel costs directly boost margins. The market has gained 17% over the past 8 weeks — one of the best stretches ever — yet historical data suggests momentum tends to persist rather than reverse.

Top Movers

DY (+29.9%) — $546.19 → $580 (+6.2% upside) Thesis: A monster earnings beat — EPS surprised by +62% and revenue by +18% on accelerating telecom infrastructure demand, with the company raising full-year guidance and announcing a data center acquisition. Revenue grew 56% YoY to $1.96B and next-quarter guidance of $1.98B is 10.8% above consensus. This is a legitimate fundamental re-rating, not a sympathy trade — the acceleration in data center/fiber buildout spending is real and DY is the picks-and-shovels play. RSI at 32.7 suggests the stock was oversold coming into this print, giving the gap room to hold. Levels: Exit near $580 (prior resistance zone). Support at $500 (pre-gap level).

QFIN (+29.15%) — $16.26 → $18.50 (+13.8% upside) Thesis: Beat on both EPS (+8.9%) and revenue (+5.05%) in a tough Chinese consumer credit environment, with management signaling risk-control measures are working. RSI at 22.4 means this was absurdly oversold (stock down 70% over the past year) before the beat. The bounce is justified given the valuation compression — this trades at rock-bottom multiples for a profitable fintech. However, China consumer credit headwinds aren’t over, so this is a mean-reversion trade, not a growth story. Levels: Exit at $18.50 (50-day mean reversion target). Support at $14.50 (pre-earnings level).

VNET (+11.09%) — $11.02 → $13.00 (+18.0% upside) Thesis: Q1 revenue grew 19.8% driven by wholesale data center expansion as AI demand surges in China. RSI at 15.8 is extremely oversold — this is a legitimate AI infrastructure play trading at depressed levels. New large-scale orders and the structural tailwind of Chinese AI buildout give this multi-quarter legs. The concern is it’s a Chinese ADR with all the associated regulatory overhang. Levels: Exit at $13.00 (200-day MA recovery). Support at $10.00 (psychological round number).

NVAX (+8.98%) — $11.40 → $13.50 (+18.4% upside) Thesis: FDA advisers are weighing an update to 2026-27 COVID vaccines targeting the XFG subvariant — this is a binary catalyst that could mean meaningful revenue for Novavax if their protein-based platform gets included. RSI at 50 is neutral, and the stock has been building a base. The +28% weekly move suggests the market is pricing in a favorable outcome. Be cautious — NVAX has a history of running on vaccine optimism then giving it back when execution disappoints. Levels: Exit at $13.50 (6-month resistance). Support at $9.50 (recent base).

RDW (+5.67%) — $23.29 → $26.00 (+11.6% upside) Thesis: SpaceX’s IPO S-1 filing has ignited a sector-wide frenzy in space stocks, with the VanEck space ETF up 24% in five days. Redwire is up 67% on the week and has RSI at 95.9 — this is dangerously overbought but momentum can persist when a catalyst this large (largest space IPO ever) is still ahead, not behind. This is a momentum trade only, not a value play. Levels: Exit at $26.00 (round number / fib extension). Support at $19.00 (pre-breakout level). CAUTION: RSI screaming overextended.

UAL (+5.93%) — $112.20 → $125 (+11.4% upside) Thesis: Double tailwind — oil crashing on Iran peace progress directly boosts airline margins, and WTI at $92.94 vs. recent highs gives UAL ~$0.50/share per $1 move in fuel savings. The +25.9% weekly move is powerful, and travel demand remains strong into summer. Airlines are operationally leveraged to fuel costs, making this a high-beta way to play the geopolitical de-escalation. Levels: Exit at $125 (pre-conflict high). Support at $100 (round number/recent base).

CCL (+4.74%) — $27.98 → $32.00 (+14.4% upside) Thesis: Same oil-crash tailwind as airlines but with RSI at 5.7 — one of the most oversold readings I’ve ever seen on a large-cap name. This was heavily shorted and beaten down on demand concerns, and now you have the CEO buying shares personally while oil collapses. The snap-back has room to run purely on the technical oversold condition normalizing. Levels: Exit at $32.00 (200-day MA). Support at $26.00 (yesterday’s close).

APP (+5.07%) — $540.29 → $600 (+11.1% upside) Thesis: News that Meta is stepping back from bidding on certain mobile advertising traffic opens up market share for AppLovin. RSI at 14.7 means this growth monster was severely oversold before this catalyst hit. APP has been one of the best growth stories in tech, and a competitive moat widening via Meta’s retreat is the kind of structural positive that justifies re-rating. High insider ownership adds conviction. Levels: Exit at $600 (psychological level / prior resistance). Support at $500 (round number / gap fill level).

STLA (+4.55%) — $8.16 → $9.50 (+16.4% upside) Thesis: Classic deep-value auto play — trades at single-digit P/E with massive cash position while peers like Tesla trade at 391x trailing. RSI at 5.5 is absurdly oversold. The catalyst here is thin (general market lift, sector comparison articles), so this is purely a mean-reversion bet on a stock that’s been punished too hard. The risk is that Stellantis has real operational problems. Levels: Exit at $9.50 (50-day MA mean reversion). Support at $7.50 (52-week low area).

BEAM (+4.53%) — $31.14 → $36.00 (+15.6% upside) Thesis: Positive Phase 1/2 data for BEAM-302 in alpha-1 antitrypsin deficiency and a potential BLA filing for sickle cell by year-end give this gene-editing name two clear catalysts. Up 60%+ over the past year with analyst targets implying ~70% further upside. This is a clinical-stage biotech with real pipeline momentum, not a speculative pre-clinical name. Levels: Exit at $36.00 (analyst consensus midpoint). Support at $28.00 (recent consolidation base).

Headlines to Watch

  • SpaceX IPO S-1 filing — The largest space IPO ever is creating a gravitational pull on the entire sector; RDW, LUNR, RKLB, VOYG all surging on sympathy flow that could persist until the actual listing.
  • US-Iran peace deal progress — Oil crashing 4.7% to $92.94 is a direct earnings catalyst for airlines (UAL, DAL), cruise lines (CCL, NCLH), and a headwind for energy names. 13 weeks of conflict may be unwinding.
  • Dycom raises full-year guidance + acquisition — Signals that US telecom/data center infrastructure spending is accelerating, not peaking. Read-through for MasTec, Quanta Services.
  • Meta stepping back from mobile ad bidding — If confirmed, this is a structural moat-widening event for AppLovin that reprices the competitive landscape.
  • S&P 500 up 17% in 8 weeks — Historical data from Creative Planning shows these rare momentum bursts tend to continue rather than mean-revert, but concentration in tech/AI makes the rally fragile to any rotation.
  • Trump’s Iran “surrender” ultimatum — Market is shrugging this off as posturing while pricing in peace, but any escalation reversal would hit travel/airline names hardest.
  • Semiconductor mania (SOXL +291% YTD) — The AI capex cycle is being priced as infinite, with MU and NVDA leading WSB fervor. Late-cycle positioning risk is building.

Claude’s Top Picks

CCL (+4.74% today, +17.1% week) — $27.98 → $32.00 (+14.4% upside) Valuation: At ~10x forward earnings with RSI at 5.7, CCL is trading at a significant discount to its own 5-year median and below Royal Caribbean on EV/EBITDA despite similar booking trends. Upside: Oil crash + CEO insider buying + extreme oversold condition = textbook snap-back setup with summer booking season as a fundamental tailwind. Risk: If Iran peace deal collapses and oil spikes back above $100, the fuel cost headwind returns immediately and demand softness the company warned about could deepen.

APP (+5.07% today, +13.29% week) — $540.29 → $600 (+11.1% upside) Valuation: Trading at roughly 25x forward earnings on 50%+ revenue growth gives a PEG ratio near 0.5 — genuinely cheap for the growth rate, even among high-growth tech peers. Upside: Meta retreating from competitive bidding is a company-specific moat expansion that removes the biggest overhang on the stock, with RSI at 14.7 providing massive room to mean-revert. Risk: The Meta story could be overblown or temporary — if Meta re-enters mobile ad auctions, the competitive narrative reverses quickly.

QFIN (+29.15% today, +27.53% week) — $16.26 → $18.50 (+13.8% upside) Valuation: Trades at ~3x trailing earnings with a P/B below 0.5 — extraordinarily cheap for a profitable fintech, even accounting for China discount; well below peers like LexinFintech and OneConnect. Upside: Earnings beat confirms the business is stabilizing after a 70% drawdown, and the RSI at 22 suggests the multi-month selling is exhausted. Risk: China consumer credit deterioration could resume, and ADR delisting risk always looms as a tail risk for Chinese names.

DY (+29.9% today, +32.14% week) — $546.19 → $580 (+6.2% upside) Valuation: At roughly 20x forward earnings with 56% revenue growth, the PEG ratio is well under 1.0 — DY is cheap relative to both its own history and infrastructure peers. Upside: Raised guidance + acquisition signals management confidence that the data center/telecom buildout cycle is accelerating; analysts will be revising estimates up today. Risk: The stock gapped up 30% in one session — some profit-taking is normal, and if the broader infrastructure spending narrative cools, DY would give back gains fast.

UAL (+5.93% today, +25.9% week) — $112.20 → $125 (+11.4% upside) Valuation: Trading at ~7x forward earnings, which is fair for an airline but cheap relative to the earnings uplift from lower fuel; Delta and Southwest trade at slight premiums on similar metrics. Upside: Every $10/barrel decline in oil is worth roughly $1.5B annually to UAL’s cost structure — if peace holds and oil stays below $95, current estimates are too low. Risk: Airlines are notoriously cyclical; any demand slowdown or peace deal reversal would hit this trade from both sides simultaneously.

Avoid

RDW (+5.67% today, +67.43% week, RSI 95.9) — Up 67% in a week on pure SpaceX IPO sympathy with no company-specific fundamental change. RSI at nearly 96 is the most extreme overbought reading on the entire board. This is a momentum lottery ticket, not an investment — chasing here after a 67% weekly run is how you become the exit liquidity.

NVAX (+8.98% today, +28.09% week, RSI 50) — Binary FDA catalyst that could easily disappoint. Novavax has a long history of running on vaccine optimism and then failing on execution. The +28% weekly move is pricing in a favorable outcome that hasn’t happened yet. Wait for the actual FDA advisory committee vote rather than paying up on anticipation.

NCLH (+6.75% today, +23.43% week, RSI 0.19) — While the oversold RSI is extreme, the company itself issued a demand warning and lowered earnings guidance. The CEO buying $2.5M in shares is a confidence signal, but insider buys often mark the beginning of a bottoming process, not the bottom itself. The oil tailwind is real but the fundamental deterioration in bookings hasn’t reversed.

WSB Sentiment Check

MU — WSB says: BULLISH (80% bullish) Claude says: PARTIALLY AGREE — Micron is legitimately benefiting from AI memory demand and UBS just raised its price target, but 2,482 mentions and 26K upvotes screams crowded trade. When everyone on WSB agrees on something at this volume, the easy money is already made. The AI memory cycle is real, but this level of retail enthusiasm often marks short-term tops rather than entries.

NVDA — WSB says: BULLISH (80% bullish) Claude says: AGREE — NVDA remains the best fundamental story in tech with earnings coming soon and every hyperscaler increasing AI capex. The consensus is right here because the earnings power justifies it. That said, expectations are so high that anything less than a massive beat + raise will disappoint. It’s expensive on trailing metrics but cheap on forward growth-adjusted basis.

LUNR — WSB says: BULLISH (80% bullish) Claude says: PARTIALLY AGREE — The SpaceX IPO filing is a real sector catalyst and LUNR (Intuitive Machines) is a direct space beneficiary with NASA contracts. The hype is justified directionally but the 80% bullish reading + space sector mania suggests the easy 20-30% move already happened. Be selective on entry rather than chasing.

AMD — WSB says: BULLISH (80% bullish) Claude says: AGREE — AMD is the value play within AI semiconductors, trading at a meaningful discount to NVDA on growth-adjusted metrics. The 15K upvotes suggest conviction rather than meme energy. AMD’s MI300X momentum and data center share gains make this a legitimate bull case. The risk is always “second place to NVDA” narrative resurfacing.

MSFT — WSB says: BULLISH (80% bullish) Claude says: AGREE — Microsoft’s AI monetization through Copilot and Azure is the most de-risked way to play the AI theme. At roughly 30x forward earnings with 15%+ growth, it’s reasonably valued for a mega-cap. This is WSB’s rare “smart money” pick — boring but correct.

Earnings Scorecard

DY — BEAT by 62% (EPS) / 18% (Revenue) | Stock: +29.9% | Reported: 2026-05-27 Before Open The reaction is justified and possibly insufficient — 56% revenue growth with raised guidance and a data center acquisition signals DY is at the epicenter of a multi-year infrastructure buildout. The market was clearly caught off-guard by the magnitude of the acceleration. This is a buy-the-dip on any pullback toward $500, not a sell-the-rip.

QFIN — BEAT by 8.9% (EPS) / 5.05% (Revenue) | Stock: +29.15% | Reported: 2026-05-26 After Close The +29% move on a modest beat looks outsized, but context matters — the stock was down 70% over the past year and trading at 3x earnings. This is less about the beat magnitude and more about proving the business isn’t deteriorating further. The reaction correctly reprices “China fintech is dying” to “China fintech is stabilizing.” Hold for another 10-15% but don’t chase aggressively.

VNET — Revenue BEAT (19.8% growth) | Stock: +11.09% | Reported: 2026-05-26 Justified reaction for a China data center play showing AI-driven demand acceleration. Management guided to ambitious growth and cited new large-scale orders. The RSI at 15.8 pre-earnings suggests the market was pricing in much worse. Room to run as the China AI infrastructure theme develops.